Health Press Releases & Articles 506 - 510 of 771
Octapharma Targeting The Major Risk Of Hemophilia Treatment - Fviii Antibodies
26th August 2009 -
Views: 727
Octapharma AG is leading an international initiative focused on confronting the major risk associated with hemophilia A therapy - anti-factor VIII (FVIII) antibodies, also known as inhibitors.
Migrant Families In Aged Care:an Intergenerational Perspective
26th August 2009 -
Views: 827
Aged care workers constantly negotiate a myriad of services with families. Often they are dealing with a number of generations within the one family.
Neostem Ceo To Participate In 2009 World Stem Cell Summit On September 23rd
26th August 2009 -
Views: 690
Dr. Smith will participate on the panel, "Cord Blood and Cell Banking: Answers for Patients, Researchers and Industry," scheduled for Wednesday, September 23rd, from 4:00 to 5:15 PM.
Moxduo(tm) Ir Demonstrates Fewer Side Effects Than Percocet(r) 1
26th August 2009 -
Views: 756
QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today successful completion of its pilot study to evaluate the analgesic efficacy and safety profile of MoxDuo(TM) IR (immediate release) capsules in patients with moderate to severe pain following total knee replacement surgery.
Outdated Processes Affect The Health And Pocket Of The Average Australian
25th August 2009 -
Views: 765
“There are 1.5 million diabetes sufferers in Australia today with another 275 Australians diagnosed every day.
NEWS 
